These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36010569)

  • 1. USP29 Deubiquitinates SETD8 and Regulates DNA Damage-Induced H4K20 Monomethylation and 53BP1 Focus Formation.
    Hernández-Reyes Y; Paz-Cabrera MC; Freire R; Smits VAJ
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for the methyltransferase SETD8 in DNA damage repair.
    Xu L; Zhang L; Sun J; Hu X; Kalvakolanu DV; Ren H; Guo B
    Clin Epigenetics; 2022 Mar; 14(1):34. PubMed ID: 35246238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
    Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
    ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha heterodimer targets the histone modification enzyme PR-Set7/Setd8 gene and regulates adipogenesis through a positive feedback loop.
    Wakabayashi K; Okamura M; Tsutsumi S; Nishikawa NS; Tanaka T; Sakakibara I; Kitakami J; Ihara S; Hashimoto Y; Hamakubo T; Kodama T; Aburatani H; Sakai J
    Mol Cell Biol; 2009 Jul; 29(13):3544-55. PubMed ID: 19414603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PR-Set7 and H4K20me1: at the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription.
    Beck DB; Oda H; Shen SS; Reinberg D
    Genes Dev; 2012 Feb; 26(4):325-37. PubMed ID: 22345514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone lysine methyltransferase Pr-set7/SETD8 promotes neural stem cell reactivation.
    Huang J; Gujar MR; Deng Q; Y Chia S; Li S; Tan P; Sung WK; Wang H
    EMBO Rep; 2021 Apr; 22(4):e50994. PubMed ID: 33565211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of histone H4 lysine 20 by PR-Set7 ensures the integrity of late replicating sequence domains in Drosophila.
    Li Y; Armstrong RL; Duronio RJ; MacAlpine DM
    Nucleic Acids Res; 2016 Sep; 44(15):7204-18. PubMed ID: 27131378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation.
    Abbas T; Shibata E; Park J; Jha S; Karnani N; Dutta A
    Mol Cell; 2010 Oct; 40(1):9-21. PubMed ID: 20932471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of lysine methyltransferase SETD8 in human diseases.
    Milite C; Feoli A; Viviano M; Rescigno D; Cianciulli A; Balzano AL; Mai A; Castellano S; Sbardella G
    Clin Epigenetics; 2016; 8():102. PubMed ID: 27688818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors of SETD8 with cellular activity.
    Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
    ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.
    Kapoor-Vazirani P; Vertino PM
    J Biol Chem; 2014 Mar; 289(11):7425-37. PubMed ID: 24459145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
    Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
    Kukita A; Sone K; Kaneko S; Kawakami E; Oki S; Kojima M; Wada M; Toyohara Y; Takahashi Y; Inoue F; Tanimoto S; Taguchi A; Fukuda T; Miyamoto Y; Tanikawa M; Mori-Uchino M; Tsuruga T; Iriyama T; Matsumoto Y; Nagasaka K; Wada-Hiraike O; Oda K; Hamamoto R; Osuga Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP29 controls the stability of checkpoint adaptor Claspin by deubiquitination.
    Martín Y; Cabrera E; Amoedo H; Hernández-Pérez S; Domínguez-Kelly R; Freire R
    Oncogene; 2015 Feb; 34(8):1058-63. PubMed ID: 24632611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of histone H4 lysine 20 methylation on 53BP1 responses to chromosomal double strand breaks.
    Hartlerode AJ; Guan Y; Rajendran A; Ura K; Schotta G; Xie A; Shah JV; Scully R
    PLoS One; 2012; 7(11):e49211. PubMed ID: 23209566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
    Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
    Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
    Ma A; Yu W; Li F; Bleich RM; Herold JM; Butler KV; Norris JL; Korboukh V; Tripathy A; Janzen WP; Arrowsmith CH; Frye SV; Vedadi M; Brown PJ; Jin J
    J Med Chem; 2014 Aug; 57(15):6822-33. PubMed ID: 25032507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of SETD8 inhibitors.
    Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J
    Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
    Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
    Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Nucleosome Substrates Improves Binding of SAM Analogs to SETD8.
    Strelow JM; Xiao M; Cavitt RN; Fite NC; Margolis BJ; Park KJ
    J Biomol Screen; 2016 Sep; 21(8):786-94. PubMed ID: 27369108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.